{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:52:57Z","timestamp":1792068777149,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.vaccine.2006.06.015","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T07:22:32Z","timestamp":1157181752000},"page":"S35-S41","source":"Crossref","is-referenced-by-count":325,"special_numbering":"S3","title":["Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Charles J.N.","family":"Lacey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Lowndes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerti V.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2006.06.015_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2006.06.015_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1523-1747.ep12276576","article-title":"Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature","volume":"85","author":"Gross","year":"1985","journal-title":"J Invest Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.06.015_bib3","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jcv.2004.10.020","article-title":"Therapy for genital human papillomavirus-related disease","volume":"32","author":"Lacey","year":"2005","journal-title":"J Clin Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.06.015_bib4","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1086\/498164","article-title":"Randomised controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination","volume":"192","author":"Vandepapeliere","year":"2005","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2006.06.015_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00007435-199711000-00003","article-title":"History of genital warts in 10,838 women 20 to 29 years of age from the general population. Risk factors and association with Papanicolaou smear history","volume":"24","author":"Munk","year":"1997","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2006.06.015_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00007435-199807000-00003","article-title":"Risk factors for incident and recurrent condylomata acuminata among women. A population-based study","volume":"25","author":"Habel","year":"1998","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2006.06.015_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"8612","key":"10.1016\/j.vaccine.2006.06.015_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(88)90469-2","article-title":"Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?","volume":"2","author":"Barton","year":"1988","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2006.06.015_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/sti.2004.009431","article-title":"The interrelation of demographic and geospatial risk factors between four common sexually transmitted diseases","volume":"81","author":"Monteiro","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2006.06.015_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/oxfordjournals.aje.a117441","article-title":"The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus","volume":"141","author":"Holmberg","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.06.015_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007435-200208000-00001","article-title":"The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts","volume":"29","author":"Silverberg","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"9296","key":"10.1016\/j.vaccine.2006.06.015_bib13","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(01)06886-6","article-title":"Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection","volume":"358","author":"Fenton","year":"2001","journal-title":"Lancet"},{"issue":"9296","key":"10.1016\/j.vaccine.2006.06.015_bib14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(01)06885-4","article-title":"Sexual behaviour in Britain: early heterosexual experience","volume":"358","author":"Wellings","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2006.06.015_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/sti.77.4.248","article-title":"The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania","volume":"77","author":"Mayaud","year":"2001","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2006.06.015_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.20242","article-title":"Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia","volume":"75","author":"Klaskala","year":"2005","journal-title":"J Med Virol"},{"issue":"1211","key":"10.1016\/j.vaccine.2006.06.015_bib18","first-page":"U1347","article-title":"Sexually transmitted infections in New Zealand in 2003","volume":"118","author":"Johnston","year":"2005","journal-title":"N Z Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2006.06.015_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/sti.79.4.270","article-title":"Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts","volume":"79","author":"Lacey","year":"2003","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2006.06.015_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% Imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.06.015_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0042-6822(03)00465-3","article-title":"Therapeutic immunisation with COPV early genes by epithelial DNA delivery","volume":"314","author":"Moore","year":"2003","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2006.06.015_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/sti.76.3.162","article-title":"European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts","volume":"76","author":"von Krogh","year":"2000","journal-title":"Sex Transm Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2006.06.015_bib25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.vaccine.2006.06.015_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archotol.125.7.743","article-title":"Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force","volume":"125","author":"Armstrong","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"12","key":"10.1016\/j.vaccine.2006.06.015_bib27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archotol.1995.01890120044008","article-title":"Task force on recurrent respiratory papillomas. A preliminary report","volume":"121","author":"Derkay","year":"1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2006.06.015_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1179\/095741905X69744","article-title":"Recurrent respiratory papillomatosis: bright prospects for vaccine-based prevention","volume":"16","author":"Shah","year":"2005","journal-title":"Papillomavirus Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2006.06.015_bib29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0029-7844(02)03081-8","article-title":"Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis","volume":"101","author":"Silverberg","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"11 Pt 2 Suppl 104","key":"10.1016\/j.vaccine.2006.06.015_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mlg.000148224.83491.0f","article-title":"Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population","volume":"114","author":"Wiatrak","year":"2004","journal-title":"Laryngoscope"},{"issue":"11","key":"10.1016\/j.vaccine.2006.06.015_bib31","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1097\/01.mlg.0000147918.81733.49","article-title":"Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer","volume":"114","author":"Reidy","year":"2004","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.vaccine.2006.06.015_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jmv.20013","article-title":"Latent Human Papillomavirus infection is comparable in the larynx and trachea","volume":"72","author":"Abramson","year":"2004","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.06.015_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archotol.130.6.711","article-title":"Clinical course of recurrent respiratory papillomatosis in Danish children","volume":"130","author":"Silverberg","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.vaccine.2006.06.015_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.moo.0000186205.91332.46","article-title":"Recurrent respiratory papillomatosis: pathogenesis to treatment","volume":"13","author":"Lee","year":"2005","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.vaccine.2006.06.015_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2006.06.015_bib36","series-title":"Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"for the FUTURE I investigators. Efficacy of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine for prevention of cervical dysplasia and external genital lesions","author":"Sattler","year":"2005"},{"issue":"11","key":"10.1016\/j.vaccine.2006.06.015_bib38","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2006.06.015_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1258\/0956462041558168","article-title":"The costs of treating external genital warts in England and Wales: a treatment pattern analysis","volume":"15","author":"Langley","year":"2004","journal-title":"Int J STD AIDS"},{"issue":"11","key":"10.1016\/j.vaccine.2006.06.015_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature","volume":"23","author":"Insinga","year":"2005","journal-title":"Pharmacoeconomics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06007274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06007274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T21:15:43Z","timestamp":1555794943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06007274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":35,"alternative-id":["S0264410X06007274"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.06.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}